Vinpocetine

Spezifikationen

42971-09-5CAS-Nummer

256-028-0EG-Nummer

ethyl (15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene-17-carboxylateIUPAC-Name

C22H26N2O2Chemische Formel

350.5 g/molMolekulargewicht

vinpocetine; 42971-09-5; Cavinton; Ceractin; Bravinton; Apovincaminic acid ethyl ester; Ethyl apovincamin-22-oate; Vinporal; Ultra-Vinca; Vinpocetinum; RGH 4405; cis-Apovincaminic acid ethyl ester; Ethyl (+)-cis-apovincaminate; TCV 3B; Vinpocetina; DTXSID5023740; NSC-760093; AY-27,255; 543512OBTC; AY-27255; DTXCID903740; ethyl (15S,19S)-15-ethyl-1,11-diazapentacyclo(9.6.2.0^(2,7).0^(8,18).0^(15,19))nonadeca-2,4,6,8(18),16-pentaene-17-carboxylate; ethyl (15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.0^{2,7}.0^{8,18}.0^{15,19}]nonadeca-2,4,6,8(18),16-pentaene-17-carboxylate; RefChem:901876; N06BX18; eburnamenine-14-carboxylic acid, ethyl ester, (3 alpha,16 alpha)-; 256-028-0; ethyl (15S,19S)-15-ethyl-1,11-diazapentacyclo(9.6.2.02,?.0?,1?.01?,1?)nonadeca-2,4,6,8(18),16-pentaene-17-carboxylate; TCV-3B; Ethyl (+)-apovincaminate; (+)-Apovincaminic acid ethyl ester; Ethyl apovincaminate; (+)-cis-Apovincaminic acid ethyl ester; AY 27,255; Eburnamenine-14-carboxylic acid, ethyl ester, (3a,16a)-; 3-alpha,16-alpha-Apovincaminic acid ethyl ester; MFCD00211233; CHEMBL71752; MLS000069635; (41S,13aS)-ethyl 13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate; Eburnamenine-14-carboxylic acid, ethyl ester, (3alpha,16alpha)-; ethyl (15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene-17-carboxylate; ethyl (41S,13aS)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate; NCGC00018204-09; SMR000058241; RGH-4405; Vinpocetinum [INN-Latin]; Apovincaminate d'ethyle; Apovincaminate d'ethyle [French]; 1H-Indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine, eburnamenine-14-carboxylic acid deriv.; ethyl (15s,19s)-15-ethyl-1,11-diazapentacyclo[9.6.2.0^{2,7}.0^{8,18}.0^{15,19}]nonadeca-2(7),3,5,8(18),16-pentaene-17-carboxylate; SR-01000075633; EINECS 256-028-0; BRN 0900803; Vinpocetin; UNII-543512OBTC; Vinpocetine (JAN/USAN/INN); Vinpocetine-ethyl apovincaminate; Eburnamenine-14-carboxylic acid ethyl ester; Vinpocetine CRS; Ethyl apovincamin; NCGC00016854-03; Vinpocetine [USAN:INN:BAN:JAN]; Prestwick_963; CAS-42971-09-5; Spectrum_001400; Vinpocetine (Cavinton); Vinpocetine (Standard); AY 27255; SpecPlus_000327; VINPOCETINE [MI]; Opera_ID_1325; Prestwick0_000268; Prestwick1_000268; Prestwick2_000268; Prestwick3_000268; Spectrum2_001529; Spectrum3_000961; Spectrum4_001075; Spectrum5_000966; VINPOCETINE [DSC]; VINPOCETINE [INN]; VINPOCETINE [JAN]; VINPOCETINE [USAN]; V 6383; VINPOCETINE [VANDF]; VINPOCETINE [MART.]; Lopac0_001257; SCHEMBL50081; BSPBio_000116; BSPBio_002561; KBioGR_001430; KBioSS_001880; VINPOCETINE [USP-RS]; VINPOCETINE [WHO-DD]; MLS001076294; DivK1c_006423; SPECTRUM1503115; Vinpocetine, >=98%, solid; ethyl (3alpha,16alpha)-eburnamenine-14-carboxylate; SPBio_001318; SPBio_002335; BPBio1_000128; cid_443955; GTPL5285; Vinpocetin - Bio-X trade mark; Vinpocetine, analytical standard; REGID_for_CID_443955; SCHEMBL29364972; CHEBI:32297; KBio1_001367; KBio2_001880; KBio2_004448; KBio2_007016; KBio3_001781; GLXC-07972; HMS1568F18; HMS1922G05; HMS2090J22; HMS2092L06; HMS2095F18; HMS3263L16; HMS3402D12; HMS3411H11; HMS3675H11; HMS3712F18; HMS3887E17; Pharmakon1600-01503115; VINPOCETINE [EP MONOGRAPH]; (3alpha, 16alpha)-Eburnamenine-14-carboxylic acid ethyl ester; MSK11212; Tox21_110648; Tox21_110839; Tox21_501257; BDBM50059033; CCG-39307; Eburnamenine-14-carboxylic acid, ethyl ester, (3-alpha,16-alpha)-; HY-13295R; NSC760093; PD-185; s2110; AKOS015896480; Tox21_110648_1; CS-0545; DB12131; EBC-574228; FV11741; LP01257; NSC 760093; SDCCGSBI-0051224.P003; Vinpocetine 1.0 mg/ml in Acetonitrile; (3S,16S)-apovincaminic acid ethylester; NCGC00018204-05; NCGC00018204-06; NCGC00018204-07; NCGC00018204-08; NCGC00018204-10; NCGC00018204-11; NCGC00018204-13; NCGC00021727-04; NCGC00021727-05; NCGC00021727-06; NCGC00021727-07; NCGC00168782-01; NCGC00261942-01; NCGC00263865-01; NCGC00263865-04; AC-22612; AS-13868; BV164528; HY-13295; ST056350; Eburnamenine-14-carboxylic acid ethyl ester;; EU-0101257; NS00006850; V0115; V3455; A12521; D01371; M02659; AB00052317_02; AO-645/21219012; Ethyl 3alpha,16alpha-eburnamenine-14-carboxylate; Q420288; SR-01000000118; SR-01000000118-3; SR-01000075633-1; SR-01000075633-3; SR-01000075633-4; BRD-K53318339-001-05-8; BRD-K53318339-001-23-1; BRD-K53318339-001-24-9; Vinpocetine Working Standard (Secondary Reference Standard); Vinpocetine, European Pharmacopoeia (EP) Reference Standard; Vinpocetine, United States Pharmacopeia (USP) Reference Standard; EBURNAMENINE 14-CARBOXYLIC ACID ETHYL ESTER (3.ALPHA.,16.ALPHA.); Cavinton; Ceractin; Bravinton; Ethyl (3alpha,16alpha)-eburnamenine-14-carboxylate; (11aS,11bS)-11a-Ethyl-2,3,4,5,11a,11b-hexahydro-1H-3a,9b-diaza-benzo[cd]fluoranthene-10-carboxylic acid ethyl ester; (3aS,11bS)-3a-ethyl-1,2,3,3a,10,11b-hexahydro-11H-5a,11a-diaza-benzo[cd]fluoranthene-5-carboxylic acid ethyl ester; (41S,13aS)-Ethyl 13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-ij]pyrido[3,2,1-de][1,5]naphthyridine-12-carboxylate; (41S,13aS)-ethyl13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate; 115986-87-3; 11a-Ethyl-2,3,4,5,11a,11b-hexahydro-1H-3a,9b-diaza-benzo[cd]fluoranthene-10-carboxylic acid 2-nitrooxy-ethyl ester(Vinpocetine); 68780-77-8; ethyl(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene-17-carboxylateSynonyme